| Surgery* (n = 63) | Neoadjuvant chemotherapy*(n = 32) | P value |
---|---|---|---|
Postoperative CEA, N% | 0.692 | ||
 Normal | 33 (63.5) | 21 (67.7) |  |
 Elevated | 19 (36.5) | 10 (32.3) |  |
Postoperative complication, N% | 0.001 | ||
 No | 46 (73.0) | 32 (100.0) |  |
 Yes | 17 (27.0) | 0 (0.0) |  |
ICU, N% | 0.042 | ||
 No | 53 (84.1) | 32 (100.0) |  |
 Yes | 10 (15.9) | 0 (0.0) |  |
Stoma, N% | 0.198 | ||
 No | 21 (33.3) | 15 (46.9) |  |
 Yes | 42 (66.7) | 17 (53.1) |  |
1-year locoregional recurrence, N% | 0.660 | ||
 No | 58 (92.1) | 31 (96.9) |  |
 Yes | 5 (7.9) | 1 (3.1) |  |
1-y Mortality, N% | 0.439 | ||
 No | 51 (82.3) | 29 (90.6) |  |
 Yes | 11 (17.7) | 3 (9.4) |  |
1-y with stoma, N% | 0.047 | ||
 No | 46 (73.0) | 29 (90.6) |  |
 Yes | 17 (27.0) | 3 (9.4) |  |
Postoperative bowel  function (days), median, (IQR) | 5.00 (3.00-6.00) | 3.00 (2.00-3.00) | < 0.001 |
 Postoperative hospital stay (days), median, (IQR) | 13.00 (10.00-19.00) | 8.00 (7.25-11.75) | < 0.001 |
 Total Hospital stay (days), median, (IQR) | 20.00 (16.00-25.00) | 15.50 (13.00-18.75) | 0.002 |
 Surgery time (min), median, (IQR) | 230.00 (180.00-300.00) | 213.00 (188.50-270.00) | 0.428 |
 Intraoperative blood loss (ml), median, (IQR) | 100.0 (50.0-200.0) | 100.00 (50.00-187.50) | 0.209 |